EUVIMEDEUVIMED entdecken
Crossref

Development of a novel predictive nomogram to prevent ‘futile surgery’ in gallbladder cancers: A single center analysis of 1196 resected gallbladder cancers

Gurudutt P Varty, Shraddha Patkar, Mufaddal Kazi, Karthik Velmurugan, Amita Sekhar Padhy, Baskaran Dhanapal, Sujat Lele, Snigdha Kamini, Abdeali Saif Arif Kaderi, Akash Pawar, Subhash Yadav, Shivakumar Gudi und 5 weitere

European Journal of Surgical Oncology · 2025

DOI: 10.1016/j.ejso.2025.110492 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Surgical Oncology, 2025. Verfasst von Gurudutt P Varty und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal and Hepato-pancreato-biliary Surgery, Department of Surgical Oncology, Tata Memorial Hospital, Homi Bhabha National In…. Hauptthemen laut MEDLINE: Gallbladder Neoplasms, Nomograms, Adenocarcinoma, Cholecystectomy. Die Arbeit nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Advancement in technical expertise, perioperative care and chemotherapeutic regimes have led to stretching the limits of surgery for gallbladder cancers (GBCs). Being an inherently aggressive cancer, do all the patients of GBCs really benefit from a surgical procedure? METHODS: A total of 1196 cases of gallbladder adenocarcinoma who underwent curative resection from January 2010 to December 2023 were analysed. FS was defined as recurrences or deaths within 6 months of surgery. A multivariate model was built and a preoperative nomogram was created. RESULTS: A total of 133 (11.1 %) patients underwent a FS with a median overall survival of 8.9 months compared to 88.7 months for patients who underwent a non-futile surgery (p < 0.001). Predefined 'TMH criteria' was used to differentiate 'borderline resectable' GBC (BR-GBC, n = 344, 28.8 %) from upfront resectable GBC (n = 852, 71.2 %) and were subjected to neoadjuvant chemotherapy. Multivariable analysis revealed log CA 19-9 (OR - 1.12, 95 %CI - 1.02-1.22, p = 0.014), borderline resectable GBCs (OR, 1.97, 95 %CI, 1.34-2.88, p = 0.001) and extended/multivisceral resection (OR - 2.01, 95 %CI - 1.13-3.45, p = 0.014) as key preoperative factors predicting a FS. A predictive nomogram was built based on these preoperative factors which had a classification accuracy of 0.888 and a precision of 0.790 on internal validation. CONCLUSION: In modern day oncology where tumour biology and patient selection assumes prime importance, incorporating our predictive nomogram in preoperative clinical decision-making pathway may guide the clinicians to avoid FS in patients of GBC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gallbladder NeoplasmsNomogramsAdenocarcinomaCholecystectomyHumansFemaleMaleMiddle AgedAgedNeoadjuvant TherapyRetrospective StudiesSurvival RateAdultAged, 80 and overNeoplasm Recurrence, Local

Autor:innen und Institutionen

  • Department of Gastrointestinal and Hepato-pancreato-biliary Surgery, Department of Surgical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, Maharashtra, India. Electronic address: gurudutt89@gm…
  • Department of Gastrointestinal and Hepato-pancreato-biliary Surgery, Department of Surgical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, Maharashtra, India. Electronic address: drshraddhapat…
  • Department of Colorectal Surgical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, Maharashtra, India. Electronic address: mufaddalkazi@live.com.
  • Department of Surgical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, Maharashtra, India. Electronic address: karthikvelmurugan27@gmail.com.
  • Department of Surgical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, Maharashtra, India. Electronic address: amitasekharpadhy@gmail.com.
  • Department of Surgical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, Maharashtra, India. Electronic address: baskarand1001@gmail.com.

Zitieren

APA

Varty, G. P., Patkar, S., Kazi, M., Velmurugan, K., Padhy, A. S., Dhanapal, B., Lele, S., Kamini, S., Kaderi, A. S. A., Pawar, A., Yadav, S., Gudi, S., Gala, K. B., Bhargava, P., Ramaswamy, A., Ostwal, V., & Goel, M. (2025). Development of a novel predictive nomogram to prevent ‘futile surgery’ in gallbladder cancers: A single center analysis of 1196 resected gallbladder cancers. European Journal of Surgical Oncology. https://doi.org/10.1016/j.ejso.2025.110492

Vancouver

Varty GP, Patkar S, Kazi M, Velmurugan K, Padhy AS, Dhanapal B, et al. Development of a novel predictive nomogram to prevent ‘futile surgery’ in gallbladder cancers: A single center analysis of 1196 resected gallbladder cancers. European Journal of Surgical Oncology. 2025. doi:10.1016/j.ejso.2025.110492

BibTeX
@article{Varty2025,
  author = {Varty, Gurudutt P and Patkar, Shraddha and Kazi, Mufaddal and Velmurugan, Karthik and Padhy, Amita Sekhar and Dhanapal, Baskaran and Lele, Sujat and Kamini, Snigdha and Kaderi, Abdeali Saif Arif and Pawar, Akash and Yadav, Subhash and Gudi, Shivakumar and Gala, Kunal B and Bhargava, Prabhat and Ramaswamy, Anant and Ostwal, Vikas and Goel, Mahesh},
  title = {Development of a novel predictive nomogram to prevent ‘futile surgery’ in gallbladder cancers: A single center analysis of 1196 resected gallbladder cancers},
  journal = {European Journal of Surgical Oncology},
  year = {2025},
  doi = {10.1016/j.ejso.2025.110492}
}
Kostenlos starten →